![](/img/cover-not-exists.png)
Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Henry, Robert R., Rosenstock, Julio, Edelman, Steven, Mudaliar, Sunder, Chalamandaris, Alexandros-Georgios, Kasichayanula, Sreeneeranj, Bogle, Allyson, Iqbal, Nayyar, List, James, Griffen, Steven C.Volume:
38
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc13-2955
Date:
March, 2015
File:
PDF, 1.09 MB
english, 2015